Symbol="TRVN"
AssetType="Common Stock"
Name="Trevena Inc"
Description="Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of new drugs for patients affected by disorders of the central nervous system. The company is headquartered in Chesterbrook, Pennsylvania."
CIK="1429560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="9596800"
EBITDA="-49689000"
PERatio="None"
PEGRatio="0"
BookValue="1.131"
DividendPerShare="0"
DividendYield="0"
EPS="-6.06"
RevenuePerShareTTM="-0.055"
ProfitMargin="0"
OperatingMarginTTM="115.85"
ReturnOnAssetsTTM="-0.609"
ReturnOnEquityTTM="-1.515"
RevenueTTM="-432000"
GrossProfitTTM="-3436000"
DilutedEPSTTM="-6.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="29.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="106.03"
PriceToBookRatio="0.569"
EVToRevenue="18.8"
EVToEBITDA="0.132"
Beta="1.914"
num_52WeekHigh="6.47"
num_52WeekLow="0.58"
num_50DayMovingAverage="0.961"
num_200DayMovingAverage="1.542"
SharesOutstanding="10969000"
DividendDate="None"
ExDividendDate="None"
symbol="TRVN"
open="0.89"
high="0.89"
low="0.86"
price="0.87"
volume="73452.00"
latest_trading_day="2023-08-11"
previous_close="0.88"
change="-0.01"
change_percent="-1.0630%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="1843395"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="1089"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_negative_thumbnail_id_2="1139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="680"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0028.jpeg"
image_positive_thumbnail_id_2="627"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
